Jericho Sciences is a pioneering brand that focuses on developing innovative antiviral therapeutics and personalized diagnostic assays. They are dedicated to addressing the limitations of current combination antiretroviral therapy (cART) in the clinical management of HIV-1 infection. Their cutting-edge research and development efforts are centered around creating long-acting antivirals that offer extended protection against viral infections.

By targeting a specific viral motif shared by multiple virus families, Jericho Sciences aims to provide effective treatment options for a wide range of viral infections. In addition to their groundbreaking therapeutics, Jericho Sciences specializes in developing clinically-relevant assays. Their J-Test Assay is designed to target both Feline Immunodeficiency Virus (FIV) and Human Immunodeficiency Virus-1 (HIV), enabling accurate and personalized diagnosis for improved patient care.

Stay updated on Jericho Sciences' progress by visiting their website. For inquiries or assistance, you can easily reach out to them through their contact information provided on their website. Trust Jericho Sciences to lead the way in revolutionizing antiviral therapies and diagnostic solutions